Search Immortality Topics:

Page 10«..9101112..2030..»

Plandai Biotechnology Inc (PLPL) Shares Tick Down -7.52% – Morgan Research

Posted: September 5, 2017 at 5:44 pm

Shares of Plandai Biotechnology Inc (PLPL) have been trending lowerover the past five bars, revealing bearishmomentum for the shares, as they ran -7.52% for the week. Looking further out we note that the shares have moved -5.38% over the past 4-weeks, -64.45% over the past half year and -38.50% over the past full year.

Plandai Biotechnology Inc (PLPL)s Williams Percent Range or 14 day Williams %R is currently at -77.00. In general, if the reading goes above -20, the stock may be considered to be overbought. Alternately, if the indicator goes under -80, this may show the stock as being oversold. The Williams Percent Range or Williams %R is a technical indicator that was developed to measure overbought and oversold market conditions. The Williams %R indicator helps show the relative situation of the current price close to the period being observed.

We can also take a look at the Average Directional Index or ADX of Plandai Biotechnology Inc (PLPL). The ADX is used to measure trend strength. ADX calculations are made based on the moving average price range expansion over a specified amount of time. ADX is charted as a line with values ranging from 0 to 100. The indicator is non-directional meaning that it gauges trend strength whether the stock price is trending higher or lower. The 14-day ADX presently sits at 54.95. In general, and ADX value from 0-25 would represent an absent or weak trend. A value of 25-50 would indicate a strong trend. A value of 50-75 would indicate a very strong trend, and a value of 75-100 would signify an extremely strong trend. At the time of writing, the 14-day Commodity Channel Index (CCI) is -70.75. Developed by Donald Lambert, the CCI is a versatile tool that may be used to help spot an emerging trend or provide warning of extreme conditions. CCI generally measures the current price relative to the average price level over a specific time period. CCI is relatively high when prices are much higher than average, and relatively low when prices are much lower than the average.

A commonly used tool among technical stock analysts is the moving average. Moving averages are considered to be lagging indicators that simply take the average price of a stock over a certain period of time. Moving averages can be very helpful for identifying peaks and troughs. They may also be used to assist the trader figure out proper support and resistance levels for the stock. Currently, the 200-day MA for Plandai Biotechnology Inc (PLPL) is sitting at 0.02. The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of stock price movements. The RSI was developed by J. Welles Wilder, and it oscillates between 0 and 100. Generally, the RSI is considered to be oversold when it falls below 30 and overbought when it heads above 70. RSI can be used to detect general trends as well as finding divergences and failure swings. The 14-day RSI is presently standing at 41.93, the 7-day is 36.38, and the 3-day is resting at 20.94.

Read this article:
Plandai Biotechnology Inc (PLPL) Shares Tick Down -7.52% – Morgan Research

Recommendation and review posted by Guinevere Smith

UW-Madison study links nicotine addiction to genetic variation in … – Madison.com

Posted: September 5, 2017 at 5:43 pm

Some smokers have more of an urge to light up right after they wake up, and UW-Madison researchers have identified a reason: genetic variation in a substance that breaks down nicotine in the brain.

The finding, by scientists at UW-Madison and Washington University in St. Louis, adds to growing research on genetic links to how much people smoke, how hard it is for them to quit and how likely they are to develop lung cancer.

Most of the attention has focused on genetic variation in enzymes that metabolize nicotine in the liver. Some studies suggest that dozens of genes could influence how addicted people become to smoking.

The new understanding about FMO3, an enzyme that metabolizes nicotine in the brain, could someday allow researchers to tailor tobacco cessation treatments to individual patients or develop new drugs to target the enzyme.

The research clearly suggests that its not just one or two big players here, but that a lot of genes may contribute to these outcomes, said Tim Baker, director of research at UW-Madisons Center for Tobacco Research and Intervention.

Despite a steady decline in smoking in recent years, tobacco remains the leading cause of preventable death, according to the Centers for Disease Control and Prevention.

About 17.3 percent of Wisconsin adults smoked in 2015. Thats down from 20.9 percent in 2011. Still, nearly 800,000 adults and adolescents in the state continue to light up, resulting in about 7,700 deaths a year, according to the state Department of Health Services.

Nationally, 17.5 percent of adults smoked in 2015, and smoking causes 480,000 deaths a year, the CDC says. More than half of American smokers attempt to quit each year, but only 6 percent succeed.

The brain enzyme study, published earlier this year in The Pharmacogenomics Journal, involved 1,558 smokers, most of them in a study at UW-Madison of people who were trying to quit.

Smokers with genes that produce more FMO3, causing nicotine to be broken down more quickly in the brain, were more likely to say they smoke first thing in the morning a key indicator of nicotine dependence.

Even if they have a home smoking ban, they will go out into their porch or to the garage to have their cigarette right away, as soon as they get up, Baker said.

Smokers with certain genetic types of the liver enzymes respond better to nicotine replacement therapy, researchers have found. Its too early to tell if the same might be true for the brain enzyme.

The genetic information could eventually help more smokers quit, but Baker said they shouldnt wait.

Regardless of their genetic status, although some people are at greater risk than others, any kind of smoking is dangerous and they should do whatever they can to quit now, he said.

Go here to see the original:
UW-Madison study links nicotine addiction to genetic variation in … – Madison.com

Recommendation and review posted by Fredricko

ASU biomedical engineer spotlighted as emerging international leader – Arizona State University

Posted: September 5, 2017 at 5:43 pm

ASU graduate and undergraduate students are getting valuable research experience in Associate Professor Sarah Stabenfeldts lab. Her work on developing new and improved approaches to treating neural injury has been highlighted by a leading international science organization. Photo by Jessica Hochreiter/ASU Download Full Image

More than 50 researchers from around the world are featured in those issues of the Journal of Materials Chemistry B and Biomaterials Science.

Stabenfeldt, an associate professor of biomedical engineering in the Ira A. Fulton Schools of Engineering at Arizona State University, is the only one among them with research papers published in the special editions of both journals.

Her work focuses on developing a variety of novel approaches to treat neural injury, primarily traumatic brain injury.

The recent publications in the Royal Society of Chemistry journals describe research by Stabenfeldt and her team of biomedical engineering graduate and undergraduate students to develop and evaluate biodegradable particles used to release small doses of therapeutic proteins to the brain over time. Recent doctoral graduate Dipankar Dutta and current doctoral student Kassondra Hickey played key roles in the projects.

Such therapeutic methods, along with the techniques and tools used to implement them, hold out hope for better ways to diagnose and treat traumatic brain injury and other neurological injuries and traumas.

Peers in the field envision her research helping to make major advances in unveiling the biological basis of traumatic brain injury, which could save the lives of thousands of patients, says Mehdi Nikkhah, a fellow Fulton Schools biomedical engineering faculty member.

Her research approach is grounded in a comprehensive understanding of the mechanisms of disease progression, and her designs for targeted therapeutics utilize some of the most cutting-edge bioengineering-based strategies, Nikkhah said. Overall, she is addressing some of our biggest healthcare challenges.

Stabenfeldts research aimed at improving the diagnosis and treatment of traumatic brain injury could saves the lives of thousands of patients, says fellow biomedical engineer Mehdi Nikkhah. Photo by Cheman Cuan/ASU

Stabenfeldt earned her doctoral degree in bioengineering from the Georgia Institute of Technology and then conducted research as a National Institutes of Health post-doctoral fellow at Georgia Tech and Emory University.

Since coming to ASU in 2011, she has co-authored more than 20 peer-reviewed articles for research publications including the particularly prominent journals Nature Materials and Biomaterials along with three book chapters.

Her work has earned support through an Arizona Biomedical Research Consortium Early Stage Investigator Award, the NIH Directors New Innovator Award and a National Science Foundation CAREER Award.

Each of these prestigious awards are given to young faculty members who are seen as future research and education leaders in their fields.

Very few junior faculty members have received more than one of these awards. This achievement undoubtedly places her among those at the forefront of biomedical engineering, Nikkhah said.

All of this recognition indicates the significant impact of Sarahs work to develop next-generation diagnostics and therapeutics for neurological-related disorders such as traumatic brain injury, said colleague David Brafman, an assistant professor of biomedical engineering in the Fulton Schools, adding that her impact extends beyond the work she is doing in her lab.

As one of the first female tenured faculty members in our program, Sarah also recognizes the importance of mentoring the next generation, Brafman said. Her service as the faculty advisor for the undergraduate Biomedical Engineering Society is one of many ways she has become a positive role model for future biomedical scientists and engineers.

The Royal Society of Chemistry, based in the United Kingdom, has more than 54,000 members worldwide.

The organization publishes more than 40 peer-reviewed research journals and many books, as well as online databases and literature updating services, covering the core chemical sciences and related fields such as biology, biophysics, energy and environment, engineering, materials, medicine and physics.

Stabenfeldt says being selected to publish in two of the societys journals highlighting emerging research leaders should boost opportunities for additional support for her projects and possibly generate invitations to present her work at medical science and bioengineering conferences.

Read abstracts of her research papers in the Journal of Materials Chemistry B and Biomaterials Science. At the end of each abstract are links to content from the recent special issues of the journals.

Continued here:
ASU biomedical engineer spotlighted as emerging international leader – Arizona State University

Recommendation and review posted by Guinevere Smith

Shenzhen Neptunus Bioengineering Co. Ltd (000078) Is Yet to See Trading Action on Sep 5 – MoneyMakingArticles

Posted: September 5, 2017 at 5:43 pm

September 5, 2017 – By Michael Collier

Shares of Shenzhen Neptunus Bioengineering Co. Ltd (SHE:000078) closed at 6.12 yesterday. Shenzhen Neptunus Bioengineering Co. Ltd currently has a total float of shares and on average sees shares exchange hands each day. The stock now has a 52-week low of 5.29 and high of 7.78.

Amid numerous setbacks in the past, China has still proven itself to have one of the most important economies not just in Asia but in the whole world. Trade and commerce is richly flourishing in the nation and the Shanghai Stock Exchange (SSE) is one of the reasons it does. It is also the best place to show full potential for Shenzhen Neptunus Bioengineering Co. Ltd and its colleagues.

The SSE, one of Chinas primary stock exchanges aside from the Shenzhen Stock Exchange, is a non-profit organization that is administered by the China Securities Regulatory Commission (CSRC). As of February, the SSE boasts with a market capitalization of $3.50 trillion, making it the fifth largest stock exchange in the world. In Asia, it is the second biggest stock exchange. The second biggest market in the world increased the chances of Shenzhen Neptunus Bioengineering Co. Ltd to catch attention of investors.

The SSE was established in 1866 but it had to close on December 5, 1941 when Japan invaded Shanghai. Operations did not resume until December 19, 1990.

Shortly after the relaunch of the SSE, the SSE Composite Index began operating on July 15, 1991 as the primary index measuring all stocks on the SSE based on market capitalization. It tracks companies using the Paasche weighted composite price index formula. Measuring more than 1,000 companies listed on the SSE means that the SSE Composite Index is a broad indicator of the Chinese economy. As a result, it had to have three sub-indices: 1) the SSE 380, which monitors the 380 most active companies; 2) the SSE 180, which monitors the 180 most active companies; and 3) the SSE 50, which monitors the 50 most active companies. Of course, in order to be included in the SSE 50, a company needs to first be included in the SSE 180 and the SSE 380. Similarly, in order for it to be included in the SSE 180, it first needs to be included in the SSE 380. The smaller the index, the clearer of a representation it is of the Chinese economy.

The SSE Composite Index has last seen its all-time high of 6,092.06 in October 2007, shortly before the 2008 Global Financial Crisis broke out; and its all-time low of 99.98 in December 1990 during the relaunch period of the SSE.

Companies listed on the SSE are classified into two types: 1) A shares, which are traded in yuan; and 2) B shares, which are traded in US dollar (USD). In the past, only domestic traders had been allowed to trade A shares. Foreign investors had been limited to B shares. However, the restriction was lifted in 2002, giving the Chinese economy more opportunities to grow immensely with greater foreign investments. It means more possibilities for Shenzhen Neptunus Bioengineering Co. Ltd.

The regular trading session on the SSE starts at 9:30 and ends at 11:30 in the morning and starts at 1:30 and ends at 3:00 in the afternoon. There is also a pre-market trading session that starts at 9:15 a.m. and lasts for 10 minutes.

China is Asias largest economy, which is why there is no better way to bet on the Asian trade and commerce environment than to invest on SSE stocks. Traders look on the liquidity of Shenzhen Neptunus Bioengineering Co. Ltd.

More important recent Shenzhen Neptunus Bioengineering Co. Ltd (SHE:000078) news were published by: Businesswire.com which released: Provision Asia and Shenzhen Hairong International Medical Development Form on June 03, 2016, also Businesswire.com published article titled: Research and Markets: Report on Health Food Industry in China 2015-2019, Marketwatch.com published: 20.05 on May 20, 2011. More interesting news about Shenzhen Neptunus Bioengineering Co. Ltd (SHE:000078) was released by: Marketwatch.com and their article: 24.59 with publication date: March 10, 2011.

Shenzhen Neptunus Bioengineering Co.,Ltd is a China firm principally engaged in pharmaceutical and food manufacturing and pharmaceutical commercial distribution businesses. The company has market cap of $. The Companys main products include anti-tumor products, cardiovascular drugs, marine drugs, respiratory drugs, anti-infective products and other pharmaceuticals, as well as healthcare products, health food and medical instrument. It currently has negative earnings.

– Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

By Michael Collier

Link:
Shenzhen Neptunus Bioengineering Co. Ltd (000078) Is Yet to See Trading Action on Sep 5 – MoneyMakingArticles

Recommendation and review posted by Guinevere Smith

Fatherhood After 40? It’s Becoming A Lot More Common – NPR

Posted: September 5, 2017 at 5:40 pm

College-educated new dads are more likely to be older, with an average age of 33. Brooke Fasani /Getty Images hide caption

College-educated new dads are more likely to be older, with an average age of 33.

If you’ve put off starting a family, you’re not alone.

In the U.S., the average age a woman gives birth to her first child has been rising. And, a study published Thursday in Human Reproduction shows dads are getting older, too.

In 1972, the average age of fathers of newborns in the U.S. was 27. Now, it’s closer to 31 years old (30.9 years to be specific), the study finds.

If you need a little reassurance that it’s not too late, consider this: Twice as many dads of newborns are now in the 40-plus age group, compared to the 1970s.

Of the roughly 4 million births each year in the U.S., about 9 percent of fathers are over 40. And “about 40,000 newborns have a father over the age of 50,” says Michael Eisenberg, an assistant professor of urology at Stanford University Medical Center and the senior author of the study. “This surprised me,” Eisenberg told us.

Eisenberg says there are potential risks and benefits of becoming a parent later in life. Typically, older mothers and fathers are farther along in their education and in their careers, “so with that comes more resources,” Eisenberg says.

So, the risks? For women, there’s an age-related decline in fertility, that can begin sooner than some women realize. The risks of chromosomal disorders increase with age, too.

But for men, the risks are less clear.

As men age, studies show that the quality of their semen declines, but “the effects of advanced paternal age are incompletely understood,” as another study points out.

Some reports have found “increased risk of autism, psychiatric illness, neurologic disease … and chromosomal abnormalities in children born to older fathers,” writes Eisenberg and his coauthors in the manuscript.

Eisenberg says here’s how he helps his patients think about the potential risks. He explains the absolute risk of having a child that develops one of these conditions is unlikely to be changed that much by being an older father. Your risk may be higher, but you’ve got to put that risk in context.

“It’s kind of like buying two lottery tickets, instead of one,” he says. “If you buy two, you’re chance of winning doubles,” but you’re still very unlikely to hit the numbers.

The U.S. isn’t alone when it comes to the rise in paternal and maternal ages. In Germany, the median age of fathers has risen to 33. And, in England, fathers aged 35 to 54 account for 40 percent of live births , according to this 2006 study.

Read this article:
Fatherhood After 40? It’s Becoming A Lot More Common – NPR

Recommendation and review posted by Fredricko

The Transgender Agenda Hits Kindergarten – National Review

Posted: September 5, 2017 at 5:40 pm

From California to Minnesota to the District of Columbia, the transgender agenda has infiltrated the classrooms of even the most tender youth. Last week Alexandra DeSanctis reported for National Review Online about the transition ceremony hosted by a kindergarten teacher at Californias Rocklin Academy Gateway to celebrate a gender-dysphoric boy donning the attire and appellation of a little girl. As DeSanctis noted, the shocked and angry parents of the Rocklin pupils had not received advance notice of the lesson and learned of the events only when their confused children returned home.

When the outraged parents complained to school administrators, the principal fell back on Rocklins non-discrimination policy and the supposed age-appropriateness of the discussions. The parents ire at the principal and, for that matter, even the school board was wrongly directed. The fault lies instead with the California legislature. Heres why.

California, like 21 other states and the District of Columbia, requires schools to notify parents of their sex-education curriculum. The Golden State also joins 35 other states and D.C. in requiring schools to allow parents to opt their children out of sex education. (Three other states require parents to opt in that is, to express consent to their childrens participation in sex-education programs.) But the California legislature specifically excluded gender identity from the states notice and opt-out requirements, by providing in Section 51932(b) of the Education Code:

This chapter does not apply to instructions, materials, presentations, or programming that discuss gender, gender identity, gender expression, sexual orientation, discrimination, harassment, bullying, intimidation, relationships, or family and do not discuss human reproductive organs and their functions.

So, contrary to the parents assumption that the local administrators of Rocklin Academy failed them and their children, the blame lies with the California legislature, which purposely exempted gender identity from both the notice and opt-out mandates of its sex-education provisions.

Paradoxically, as Matt Sharp, senior counsel at Alliance Defending Freedom, a legal-advocacy non-profit organization working with allies in California to protect parental rights, highlighted in an e-mail interview: What is so troubling is that, under California law, schools must provide notification and an opt-out before they discuss certain biological truths of human reproduction between males and females, but not when they teach the rejection of those biological truths.

California is unique in that its legislature expressly excluded classroom instruction related to gender identity from the states sex education notice and opt-out requirements. However, while other states have not (yet) taken this direct approach, parents might be surprised to learn that the of law of their state likely provides them with no better protection.

For instance, the Colorado Comprehensive Health Education Act provides that local school boards and districts must provide written notification to parents of any comprehensive health education program and allow parents to opt their students out of the curriculum. But the statute defines comprehensive health education program to mean a planned, sequential health program of learning experiences in preschool, kindergarten, and grades one through twelve.

Given Colorados definition of comprehensive health education program, an event such as occurred at Rocklin Academy would not trigger the notice and opt-out provisions. A morning spent reading a picture book, followed by the introduction of a boy, his brief disappearance for a wardrobe change, and then reentry with a new feminine name and attire hardly qualifies as a planned sequential health program of learning experiences. Instead, the school would view such events as anti-bullying education.

While Californias explicit exemption of gender identity from the notice and opt-out provisions of state law is an outlier, Colorados approach is not. Rather, it appears to be the norm. Consider, for example, the District of Columbias notice and opt-out regulations:

Prior to offering human sexuality and reproduction courses or programs, the principal shall notify in writing the parents or guardians of minor students. A minor student shall be excused from participating in human sexuality and reproduction instruction upon receipt by the principal of written notification from the students parent or guardian.

Given the human sexuality and reproduction language used in the regulations, gender-identity or transgenderism lessons would not trigger D.C.s notice and opt-out mandates either. Many other states use similar statutory or regulatory language, leaving parents without recourse to protect their children from being taught a transgender agenda in the public school system.

Nor will parents prevail in litigation should they turn instead to the courts and the Constitution. Rather, as I explained in detail last week at the Federalist in Why the Most Realistic Solution to Schools Trans Indoctrination Is Withdrawing Your Kids, a claim that transgender school lessons infringe on free-exercise rights or violate constitutionally protected parental rights would fail.

However, for those unwilling or unable to abandon the public school system, one other option remains: Lobbying state legislatures to extend (or create) notice and opt-out rights for issues related to gender identity. Minnesota, New Hampshire, and Texas already provide parents a blanket opt-out right for all aspects of the schools curriculum. Concerned parents should push their own state legislatures to follow suit, or at least guarantee the right of parents to opt their children out of lessons covering issues of gender and gender identity. But time is of the essence, because kids grow up so fast and that process is already difficult enough as it is. Schools shouldnt be making it harder.

READ MORE:Forcing Transgender Ideology on KindergartensThe Tragic Transgender ContagionChelsea Manning and the Problem with Pronouns

Margot Cleveland is a lawyer, CPA, stay-at-home mom, and former full-time faculty member and current adjunct professor at the college of business at the University of Notre Dame. She can be reached at[emailprotected].

Read more:
The Transgender Agenda Hits Kindergarten – National Review

Recommendation and review posted by Guinevere Smith


Page 10«..9101112..2030..»